Novavax

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Novavax 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About NVAX

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. 

CEO
John C.s Jacobs
CEOJohn C.s Jacobs
Employees
749
Employees749
Headquarters
Gaithersburg, Maryland
HeadquartersGaithersburg, Maryland
Founded
1987
Founded1987
Employees
749
Employees749

NVAX Key Statistics

Market cap
1.28B
Market cap1.28B
Price-Earnings ratio
-13.24
Price-Earnings ratio-13.24
Dividend yield
Dividend yield
Average volume
3.09M
Average volume3.09M
High today
$8.02
High today$8.02
Low today
$7.72
Low today$7.72
Open price
$7.83
Open price$7.83
Volume
1.56M
Volume1.56M
52 Week high
$11.97
52 Week high$11.97
52 Week low
$6.20
52 Week low$6.20

Stock Snapshot

The current Novavax(NVAX) stock price is $7.76, with a market capitalization of 1.28B. The stock trades at a price-to-earnings (P/E) ratio of -13.24.

As of 2026-07-23, Novavax(NVAX) stock has fluctuated between $7.72 and $8.02. The current price stands at $7.76, placing the stock +0.5% above today's low and -3.3% off the high.

The Novavax(NVAX)'s current trading volume is 1.56M, compared to an average daily volume of 3.09M.

During the past year, Novavax(NVAX) stock moved between $6.20 at its lowest and $11.97 at its peak.

During the past year, Novavax(NVAX) stock moved between $6.20 at its lowest and $11.97 at its peak.

NVAX News

Nasdaq 1d
Novavax, Inc. is Attracting Investor Attention: Here is What You Should Know

Novavax (NVAX) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the n...

Novavax, Inc. is Attracting Investor Attention: Here is What You Should Know
MarketWatch 2d
Novavax Inc. stock outperforms competitors on strong trading day - MarketWatch

...

Novavax Inc. stock outperforms competitors on strong trading day - MarketWatch
Simply Wall St 6d
Novavax Stock Still Looks Pricey As Sales Struggle To Support It

Novavax stock has delivered a steep decline of around 96% over the past five years, yet its current valuation checks and recent 12 month gain of 17.3% leave a m...

Novavax Stock Still Looks Pricey As Sales Struggle To Support It

Analyst ratings

56%

of 9 ratings
Buy
55.6%
Hold
11.1%
Sell
33.3%

People also own

Based on the portfolios of people who own NVAX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.